Author:
Verrest Luka,Wasunna Monique,Kokwaro Gilbert,Aman Rashid,Musa Ahmed M.,Khalil Eltahir A. G.,Mudawi Mahmoud,Younis Brima M.,Hailu Asrat,Hurissa Zewdu,Hailu Workagegnehu,Tesfaye Samson,Makonnen Eyasu,Mekonnen Yalemtsehay,Huitema Alwin D. R.,Beijnen Jos H.,Kshirsagar Smita A.,Chakravarty Jaya,Rai Madhukar,Sundar Shyam,Alves Fabiana,Dorlo Thomas P. C.
Funder
Médecins Sans Frontières
Drugs for Neglected Diseases initiative
Department for International Development
Médecins Sans Frontières/Doctors without Borders, International
Ministry of Foreign and European Affairs (MAEE), France; Region of Tuscany, Italy; République and Canton de Geneva, Switzerland
Medicor Foundation, Liechtenstein
Fondation Pro Victimis, Switzerland
Fondation André & Cyprien, Switzerland
Spanish Agency for International Development Cooperation (AECID), Spain
Swiss Agency for Development and Cooperation (SDC), Switzerland
Bill and Melinda Gates Foundation
Institute for OneWorld Health
Special Program for Research and Training in Tropical Diseases (TDR) of the United Nations Development Program
World Health Organization
Second European and Developing Countries Clinical Trials Partnership Programme
ZonMw/Dutch Research Council
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology